Save information for later
Sign Up

Learn About Lewy Body Dementia (LBD)

What is the definition of Lewy Body Dementia (LBD)?
Lewy body dementia is one of the most common forms of progressive dementia. People affected by this condition may experience a variety of symptoms such as changes in alertness and attention; hallucinations; problems with movement and posture; muscle stiffness; confusion; and/or memory loss. Although the exact cause of Lewy body dementia is poorly understood, symptoms are thought to result when clumps of a protein called alpha-synuclein ("Lewy bodies") accumulate in the brain. Lewy body dementia usually occurs sporadically in people with no family history of the condition. Rarely, more than one family member may be affected.
What are the alternative names for Lewy Body Dementia (LBD)?
  • Lewy body dementia
  • Autosomal dominant diffuse Lewy body disease
  • DLB
  • Diffuse Lewy body disease
  • Lewy body disease
Who are the top Lewy Body Dementia (LBD) Local Doctors?
Elite in Lewy Body Dementia (LBD)
Elite in Lewy Body Dementia (LBD)

Johns Hopkins Outpatient Center

Baltimore, MD 
Languages Spoken:
English, German

Dr. Scholz is a neurologist and geneticist specializing in neurodegenerative disorders such as Parkinson's disease, atypical parkinsonism and dementia syndromes. She received her medical degree from the Medical University Innsbruck, Austria. Following graduation, she was a postdoctoral fellow at the National Institutes of Health under the supervision of Drs. Andrew Singleton and John Hardy. She obtained a Ph.D. in neurogenomics from the University College London, UK in 2010. She then moved to Baltimore to complete her neurology residency training at Johns Hopkins. In 2015 Dr. Scholz received the McFarland Transition to Independence Award for Neurologist-Scientists. She is Lasker Clinical Research Scholar at the National Institute of Neurological Disorders and Stroke focusing on genetic causes of neurodegenerative syndromes, and an adjunct faculty member at Johns Hopkins' department of neurology. Dr. Scholz is rated as an Elite provider by MediFind in the treatment of Lewy Body Dementia (LBD). Her top areas of expertise are Lewy Body Dementia (LBD), Multiple System Atrophy, Movement Disorders, and Parkinson's Disease.

Elite in Lewy Body Dementia (LBD)
Elite in Lewy Body Dementia (LBD)

Penn Neurology Pennsylvania Hospital

330 South 9th Street, 3rd Floor, 
Philadelphia, PA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Andrew Siderowf is a Neurologist in Philadelphia, Pennsylvania. Dr. Siderowf is rated as an Elite provider by MediFind in the treatment of Lewy Body Dementia (LBD). His top areas of expertise are Parkinson's Disease, Movement Disorders, Lewy Body Dementia (LBD), and Dementia. Dr. Siderowf is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Lewy Body Dementia (LBD)
Elite in Lewy Body Dementia (LBD)

Penn Neurology Pennsylvania Hospital

330 South 9th Street, 3rd Floor, 
Philadelphia, PA 
Languages Spoken:
English

Alice Chen is a Neurologist in Philadelphia, Pennsylvania. Dr. Chen is rated as an Elite provider by MediFind in the treatment of Lewy Body Dementia (LBD). Her top areas of expertise are Parkinson's Disease, Movement Disorders, Lewy Body Dementia (LBD), and Dementia.

What are the latest Lewy Body Dementia (LBD) Clinical Trials?
Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia

Summary: The proposed study aims to address the critical gaps in understanding the mechanisms of CF (Cognitive Fluctuations) by leveraging recently emerged molecular biomarkers, advanced neuroimaging techniques to assess measures of cholinergic degeneration, and synchronous EEG and assessments of attention. One of the overarching innovations of study is combining all of these assessments into one integrate...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Double-Blind, Placebo-Controlled, Phase 2, Efficacy and Safety Study of ACP-204 in Adults With Lewy Body Dementia Psychosis (LBDP)

Summary: Multicenter, randomized, 6-week, double-blind, placebo-controlled, parallel-group, Phase 2 study in subjects with LBDP.

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center